Compound ID | 481
Class: Fluoroquinolone
Spectrum of activity: | Gram-negative |
Details of activity: | DNA gyrase inhibitor; Cell membrane inhibitor; effective against MRSA |
Description: | Arginine salt of the tricyclic fluoroquinolone S-(−)-nadifloxacin |
Institute where first reported: | Wockhardt, India |
Year first mentioned: | 2001 |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
External links: | |
Guide to Pharmacology: | levonadifloxacin |